These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 30007463)

  • 1. Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
    Bonadonna P; Scaffidi L
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):455-468. PubMed ID: 30007463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected.
    Bonadonna P; Zanotti R; Pagani M; Bonifacio M; Scaffidi L; Olivieri E; Franchini M; Reccardini F; Costantino MT; Roncallo C; Mauro M; Boni E; Rizzini FL; Bilò MB; Marcarelli AR; Passalacqua G
    J Allergy Clin Immunol Pract; 2018; 6(4):1368-1372. PubMed ID: 29258788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder?
    Brockow K; Akin C
    Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):356-362. PubMed ID: 28796123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
    González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
    Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?
    Sahiner UM; Durham SR
    Front Immunol; 2019; 10():1959. PubMed ID: 31497015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastocytosis and Hymenoptera venom allergy.
    Ruëff F; Placzek M; Przybilla B
    Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):284-8. PubMed ID: 16825870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G; Brönnimann M; Hunziker T; Müller U
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.
    Jarkvist J; Salehi C; Akin C; Gülen T
    Allergy; 2020 Jan; 75(1):169-177. PubMed ID: 31306487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
    Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
    Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis.
    Kors JW; van Doormaal JJ; de Monchy JG
    J Intern Med; 1993 Mar; 233(3):255-8. PubMed ID: 8450293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylaxis and mast cell disease: what is the risk?
    Akin C
    Curr Allergy Asthma Rep; 2010 Jan; 10(1):34-8. PubMed ID: 20425512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.